Stroke Management Market 2021 By Industry Trends & Regional Forecast To 2027

Stroke Management Market 2021 By Industry Trends & Regional Forecast To 2027


Globally, stroke management market size will be augmented by the rising prevalence of chronic diseases such as diabetes, cardiovascular, cancer, and others. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) cause a greater number of deaths as compared to other chronic diseases, with nearly 17.9 million deaths each year.

Additionally, people with pre-existing medical conditions are more vulnerable to heart attacks and fatal infection of COVID-19, propelling demand for stroke management solutions in the recent future. The escalating adoption of mobile stroke treatment units to treat patients will foster the industry expansion. Reportedly, global stroke management market size is projected to surpass US$47 billion by 2026.

Request for a sample copy of this report @

Robust technological advancement in the procedure of stroke treatment and diagnosis will boost the market growth and facilitate faster recovery of patients. For example, B. Braun joined hands with NuMED Inc., in May 2019, to introduce the NuDEL CP Stent delivery system that is useful for the treatment of right ventricular outflow.

Earlier, it was believed that thrombectomy, which removes a blood clot from the blood vessels, is the only surgical procedure feasible for patients within the first six hours of the stroke. However, according to recent trials, it is found that thrombectomy can be effective up to 24 hours after the stroke to the patients.

Based on type, the stroke management market is categorized into ischemic, hemorrhagic, transient ischemic attack, and others. The escalating prevalence of severe ailments like blood pressure and cholesterol has resulted in a rising number of neurological and cardiac disorders. The transient ischemic attack (TIA) category is projected to observe substantial growth between 2019 and 2026.

The elderly population is more vulnerable to transient ischemic attack, as the chances of getting stroke increases along with the age. The introduction of technologically advanced procedures such as CT angiography that detects transient ischemic attack symptoms reflects significant development in medical science.

Request for customization @

Stroke management market, based on diagnostics is categorized into a computed tomography scan (CT scan), carotid ultrasound, cerebral angiography, magnetic resonance imaging (MRI), electrocardiography, and others. Most methods see widespread adoption depending on patient needs, operational costs and effectiveness.

The carotid ultrasound category held a market value of US$4 billion in 2019. As compared to conventional angiography, carotid ultrasound renders benefits such as improved safety and lower chances of radiation to patients. Additionally, as compared to other imaging solutions, ultrasound scanning renders an explicit picture of soft tissues.

Stoke management therapeutic devices available in the market are embolic coils, aspiration catheters, surgical clipping, stent retrievers, flow diverters, and others. Embolic coils provide many benefits including better physiological outcome, low risk of epilepsy, and easy entrance to the vertebrobasilar system.

Notably, the embolic coils segment will rise at over 6% CAGR up to 2026. The escalating preference of embolic coiling procedure over surgical clipping for treating intracranial aneurysms will propel industry expansion in the coming years.

The stroke management industry in the Asia Pacific is poised to observe nearly 7% CAGR in the coming years. The escalating demand for medical devices regionally is augmented by rising prevalence of cardiovascular diseases, with surging incidences of heart attacks or strokes in geriatric population. Excluding countries like Japan, the mortality rate caused by strokes in Asia is much higher than in America and Western Europe, resulting in high demand for stroke management devices.

Also, there are surging number of specialized hospitals and diagnostic centers for treating patients suffering from cardiovascular diseases in Asia Pacific. Leading companies offering stroke management solutions are B. Braun Melsungen AG, Medtronic, Integer Holdings, Claret Medical, GE Healthcare, Penumbra, Johnson & Johnson, Siemens, and Abbott Laboratories.

Partial Chapter of the Table of Content

Chapter 2.  Executive Summary

2.1. Stroke management industry 3600 synopsis, 2015 - 2026

2.1.1.  Business trends

2.1.2.  Type trends

2.1.3.  Diagnostics trends

2.1.4.  Therapeutic devices trends

2.1.5.  End-use trends

2.1.6.  Regional trends

Chapter 3.  Stroke Management Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1.  Growth drivers   Growing preference for minimally invasive procedures   Increasing prevalence of cardiovascular diseases worldwide   Technological advancements   Growing geriatric population in developed economies

3.3.2.  Industry pitfalls and challenges   Stringent regulatory framework   High cost of procedures

3.4. Growth potential analysis

3.4.1.  By type

3.4.2.  By diagnostics

3.4.3.  By therapeutic devices

3.4.4.  By end-use

3.5. COVID-19 impact analysis

3.6. Porter’s analysis

3.7. Competitive landscape, 2019

3.7.1.  Strategy dashboard

3.8. PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @